Characteristic | Total cohort (N = 24) | Cluster-poor patients (N = 12) | Cluster-rich patients (N = 12) | p-value | n |
---|---|---|---|---|---|
Age (years) | 62.3 ± 11.5 | 67.3 ± 9 | 57.4 ± 11.2 | 0.064 | 24 |
White blood cells (cells/µL) | 2580 ± 2570 | 2729 ± 2870 | 2431 ± 2350 | 0.954 | 24 |
Macrophages (cells/µL) | 807 ± 1084 | 738 ± 1053 | 876 ± 1157 | 0.843 | 24 |
Lymphocytes (cells/µL) | 1005 ± 1083 | 1132 ± 1215 | 878 ± 971 | 0.506 | 24 |
Neutrophils (cells/µL) | 762 ± 1010 | 853 ± 959 | 672 ± 1094 | 0.843 | 24 |
Sugarbaker score/PCI | 21 ± 6.3 | 20.5 ± 6.5 | 21.6 ± 6.4 | 1 | 23 |
BMI | 25.8 ± 6.6 | 25.6 ± 4.3 | 26 ± 8.5 | 0.544 | 24 |
WHO performance status | 0.5 ± 0.8 | 0.8 ± 0.9 | 0.2 ± 0.6 | 0.022 | 22 |
CA125 at detection (UI) | 2826 ± 5103 | 3746 ± 7284 | 1990 ± 1648 | 0.605 | 21 |